Skip to main content
Qiuping Ma

Qiuping Ma

Staff Pathologist, and Director of Core Lab and Point of Care, Department of Pathology, Veterans Affairs Long Beach

Biography

Qiuping Ma, MD, PhD, is a Staff Pathologist and Director of Core Lab and Point of Care in the Department of Pathology at Veterans Affairs Long Beach. Ma received an MB from Peking University Health Science Center and an MMed in Gynecologic Oncology from Sun Yat-sen Memorial Hospital in China, followed by a PhD in Pathology from the College of Medicine at the University of South Florida. Ma completed residency training in Internal Medicine and OB/GYN in China, followed by a research fellowship in Medical Oncology at Dana-Farber Cancer Institute and Harvard Medical School, residency and fellowship training in Pathology and Surgical Pathology at the Hospital of the University of Pennsylvania, and a fellowship in GI/Liver/Pancreas Pathology at Duke University Medical Center.

Ma's research has focused on mechanisms of nuclear receptor function in prostate and ovarian cancers, as well as biological processes and therapeutic vulnerabilities in esophageal, gastric, pancreatic, and lung cancers. During the research fellowship at Dana-Farber Cancer Institute from 2008 to 2014, Ma contributed to studies on squamous cell carcinomas and gastroesophageal adenocarcinoma models. Ma has also completed quality improvement projects in surgical pathology, microbiology, and molecular diagnostics, including work on pancreatic neuroendocrine tumors and colon cancer.

Ma has served as a Staff Pathologist at Veterans Affairs Pittsburgh Healthcare System and University of Pittsburgh Medical Center before joining Veterans Affairs Long Beach in 2022. Ma has been involved in teaching medical students, residents, and fellows at the University of Pennsylvania, Duke University Medical Center, University of Pittsburgh Medical Center, and Veterans Affairs Long Beach, including didactic lectures and mentoring activities. Ma holds unrestricted medical licenses in Pennsylvania and California.

Return to top

Education

  • MB, Peking University Health Science Center, China, 1997
  • MMed in Gynecologic Oncology, Sun Yat-sen Memorial Hospital, China, 2001
  • PhD in Pathology, University of South Florida, 2008
Return to top

Areas of Expertise

  • Gastrointestinal Pathology
  • Nuclear Receptor Function
  • Ovarian Cancer Therapeutics
  • Androgen Receptor Signaling
  • Squamous Cell Carcinoma Genetics
  • Peripheral Nerve Sheath Tumors
  • Hepatic Neoplasm Diagnosis

Recent Publications

  • Kapila K, Ma Q, King LY, “It Ain't Over Till It's Over”, Clin Liver Dis (Hoboken), vol. 16, no. 2, pp. 33–37, 2020.
  • Watanabe H, Ma Q, Peng S, Adelmant G, Swain D, Song W, Fox C, Francis JM, Pedamallu CS, Deluca DS, Brooks AN, Wang S, Que J, Rustgi AK, Wong KK, Ligon KL, Liu XS, Marto JA, Meyerson M, Bass AJ, “SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas”, The Journal of Clinical Investigation, vol. 124, no. 4, pp. 1636-45, 2014.
  • Hong YS, Kim J, Pectasides E, Fox C, Hong SW, Ma Q, Wong GS, Peng S, Stachler MD, Thorner AR, Van Hummelen P, Bass AJ, “Src Mutation Induces Acquired Lapatinib Resistance in ERBB2-Amplified Human Gastroesophageal Adenocarcinoma Models” (opens in new tab), PLoS One, vol. 9, no. 10, pp. e109440, 2014.
  • Yang Y, Tse AK, Li P, Ma Q, Xiang S, Nicosia SV, Seto E, Zhang X, Bai W, “Inhibition of androgen receptor activity by histone deacetylase 4 through receptor SUMOylation”, Oncogene, vol. 30, no. 19, pp. 2207-18, 2011.
  • Fu W, Ma Q, Chen L, Li P, Zhang M, Ramamoorthy S, Nawaz Z, Shimojima T, Wang H, Yang Y, Shen Z, Zhang Y, Zhang X, Nicosia SV, Zhang Y, Pledger JW, Chen J, Bai W, “MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradation”, The Journal of Biological Chemistry, vol. 284, no. 21, pp. 13987-4000, 2009.
  • Ma Q, Fu W, Li P, Nicosia SV, Jenster G, Zhang X, Bai W, “FoxO1 mediates PTEN suppression of androgen receptor N- and C- terminal interactions and coactivator recruitment”, Molecular Endocrinology, vol. 23, no. 2, pp. 213-225, 2009.
  • Zhang X, Jiang F, Li P, Li C, Ma Q, Nicosia SV, Bai W, “Growth suppression of ovarian cancer xenografts in nude mice by vitamin D analogue EB1089”, Clin Cancer Res, vol. 11, no. 1, pp. 323-8, 2005.
  • Ma Q, Lin Z, Zeng D, Wei Q, Yang Q, “The combined effect of 1,25-dihydroxyvitamin D3 and carboplatin on cell growth in human ovarian cancer cell lines in vitro”, Chinese Journal of Obstetrics and Gynecology, vol. 37, no. 7, pp. 432-433, 2002.
  • Lin Z, Zhou H, Long Q, Zhang B, Zeng Y, Ma Q, “Experimental study of drug concentration in retroperitoneal lymph node via Paraaortic cannulation”, Chinese Journal of Practical Gynecology and Obstetrics, vol. 17, no. 8, pp. 469-472, 2001.
  • Ma Q, Lin Z, “The effect of 1,25(OH)2VitD3 on gynecologic tumors(review)”, Current Advances in Obstetrics and Gynecology (Chinese), vol. 10, no. 6, pp. 447-448, 2001.
  • Zeng D, Lin Z, Chen Q, Wei Q, Ma Q, Zhou H, “Growth inhibition in ovarian cancer cells transfected with wild-type p53 gene”, Current Advances in Obstetrics and Gynecology (Chinese), vol. 9, no. 4, pp. 246-249, 2000.
  • Lin Z, Ma Q, “The water, electrolyte, acid and base balance during perioperation (review)”, Chinese Journal of Practical Gynecology and Obstetrics, vol. 15, no. 11, pp. 726-727, 1999.
Return to top

Contact Information

Email: qiupingm@uci.edu

Phone: (562) 826-8000

Address: LBVA

Return to top

This profile was created with the help of AI.

Last updated on 5/14/2026.